Conversely, MDM2/CDK4 amplifications, a consistent finding in approximately a quarter of adenosarcomas (Howitt et al., 2015; Piscuoglio et al., 2016a), were absent in PTs (Fig. 6C). This evidence concerns the gene CDK4 and adenosarcoma.